Loading...
Loading...
A validated risk stratification tool for adult cancer patients with febrile neutropenia (FN) that identifies low-risk patients who may be suitable for oral antibiotic therapy or early discharge. Developed and validated by the Multinational Association for Supportive Care in Cancer (MASCC). A score ≥21 identifies patients at low risk for serious medical complications.
Burden of Febrile Neutropenia / Severity of Illness
No Hypotension at Presentation
No COPD (Active Chronic Obstructive Pulmonary Disease)
Solid Tumor OR Hematologic Malignancy with No Previous Fungal Infection
No Dehydration Requiring IV Fluids
Outpatient Status at Time of Febrile Neutropenia Onset
Age < 60 Years
Awaiting input
Fill in the parameters to see your result